Sender Co & Partners Inc. Cuts Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Sender Co & Partners Inc. reduced its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 69.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,566 shares of the company's stock after selling 59,324 shares during the period. Kenvue accounts for 0.7% of Sender Co & Partners Inc.'s holdings, making the stock its 25th biggest holding. Sender Co & Partners Inc.'s holdings in Kenvue were worth $591,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Riverview Trust Co acquired a new stake in Kenvue in the 3rd quarter valued at $30,000. Ashton Thomas Securities LLC bought a new position in Kenvue in the 3rd quarter valued at about $35,000. Studio Investment Management LLC boosted its stake in Kenvue by 52.1% during the 2nd quarter. Studio Investment Management LLC now owns 2,468 shares of the company's stock valued at $45,000 after purchasing an additional 845 shares during the last quarter. Deseret Mutual Benefit Administrators increased its holdings in Kenvue by 49.7% during the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company's stock worth $45,000 after purchasing an additional 651 shares in the last quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in Kenvue during the 2nd quarter worth approximately $61,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on KVUE. Bank of America upped their price target on Kenvue from $24.00 to $27.00 and gave the stock a "buy" rating in a report on Tuesday, October 22nd. Royal Bank of Canada cut shares of Kenvue from an "outperform" rating to a "sector perform" rating and set a $24.00 target price on the stock. in a research report on Tuesday, September 24th. Piper Sandler increased their target price on shares of Kenvue from $20.00 to $21.00 and gave the company a "neutral" rating in a research report on Monday, September 23rd. JPMorgan Chase & Co. lifted their price target on shares of Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Finally, Jefferies Financial Group assumed coverage on Kenvue in a report on Tuesday, September 24th. They set a "buy" rating and a $27.00 price objective for the company. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Kenvue has a consensus rating of "Hold" and a consensus target price of $22.64.

Kenvue Price Performance

NYSE KVUE traded up $0.06 during trading on Tuesday, reaching $22.87. The company's stock had a trading volume of 4,181,735 shares, compared to its average volume of 17,693,963. The firm has a fifty day moving average of $22.96 and a 200 day moving average of $21.13. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46. The stock has a market capitalization of $43.85 billion, a PE ratio of 41.47, a P/E/G ratio of 2.07 and a beta of 1.37. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.01. The business had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. Kenvue's quarterly revenue was down .4% on a year-over-year basis. During the same period last year, the firm posted $0.31 earnings per share. Analysts expect that Kenvue Inc. will post 1.07 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th were paid a $0.205 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a yield of 3.59%. Kenvue's dividend payout ratio is presently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.